Deval Lashkari's Email & Phone

Dr. Lashkari has worked in the life sciences area since 1988 developing and commercializing novel technologies. He gained corporate and business development experience through senior management positions in a number of biotechnology companies. In addition, he was a founding Research Director at Synteni, which was acquired by Incyte Genomics, where he was Director of Product Development. He also worked with Operon Technologies, acquired by Qiagen, and Genometrix. Dr. Lashkari has represented THP on the boards of AcroMetrix (acquired by Life Technologies), Althea Technologies, AltheaDx, Applied Precision, Aurora Discovery, NEXUS Biosystems and SwitchGear Genomics. Dr. Lashkari received a BA from the University of California, Berkeley and a Ph.D. from Stanford University.